355 related articles for article (PubMed ID: 27882334)
41. Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies.
Horowitz NB; Mohammad I; Moreno-Nieves UY; Koliesnik I; Tran Q; Sunwoo JB
Front Immunol; 2021; 12():648580. PubMed ID: 33968039
[TBL] [Abstract][Full Text] [Related]
42. Re(de)fining Innate Lymphocyte Lineages in the Face of Cancer.
Chou C; Li MO
Cancer Immunol Res; 2018 Apr; 6(4):372-377. PubMed ID: 29610422
[TBL] [Abstract][Full Text] [Related]
43. Diversity and function of group 1 innate lymphoid cells.
Cortez VS; Colonna M
Immunol Lett; 2016 Nov; 179():19-24. PubMed ID: 27394699
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation.
Nau D; Altmayer N; Mattner J
J Immunol Res; 2014; 2014():546596. PubMed ID: 24987710
[TBL] [Abstract][Full Text] [Related]
45. ROLE OF INNATE LYMPHOID CELLS DURING CANCER.
Tashireva LA; Zavgorodskaya KO; Perelmuter VM
Tsitologiia; 2016; 58(12):901-7. PubMed ID: 30188105
[TBL] [Abstract][Full Text] [Related]
46. The Role of NK Cells and Innate Lymphoid Cells in Brain Cancer.
Sedgwick AJ; Ghazanfari N; Constantinescu P; Mantamadiotis T; Barrow AD
Front Immunol; 2020; 11():1549. PubMed ID: 32903717
[TBL] [Abstract][Full Text] [Related]
47. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
48. NK Cell Anti-Tumor Surveillance in a Myeloid Cell-Shaped Environment.
Russo E; Laffranchi M; Tomaipitinca L; Del Prete A; Santoni A; Sozzani S; Bernardini G
Front Immunol; 2021; 12():787116. PubMed ID: 34975880
[TBL] [Abstract][Full Text] [Related]
49. Flt3 ligand expands bona fide innate lymphoid cell precursors in vivo.
Parigi SM; Czarnewski P; Das S; Steeg C; Brockmann L; Fernandez-Gaitero S; Yman V; Forkel M; Höög C; Mjösberg J; Westerberg L; Färnert A; Huber S; Jacobs T; Villablanca EJ
Sci Rep; 2018 Jan; 8(1):154. PubMed ID: 29317685
[TBL] [Abstract][Full Text] [Related]
50. ILC2 Activation by Protozoan Commensal Microbes.
Burrows K; Ngai L; Wong F; Won D; Mortha A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574995
[TBL] [Abstract][Full Text] [Related]
51. ILC regulation of T cell responses in inflammatory diseases and cancer.
Warner K; Ohashi PS
Semin Immunol; 2019 Feb; 41():101284. PubMed ID: 31383506
[TBL] [Abstract][Full Text] [Related]
52. Innate lymphoid cells: key players in tissue-specific immunity.
Turner JE; Gasteiger G
Semin Immunopathol; 2018 Jul; 40(4):315-317. PubMed ID: 29951905
[No Abstract] [Full Text] [Related]
53. Development and differentiation of early innate lymphoid progenitors.
Harly C; Cam M; Kaye J; Bhandoola A
J Exp Med; 2018 Jan; 215(1):249-262. PubMed ID: 29183988
[TBL] [Abstract][Full Text] [Related]
54. Plasticity of Innate Lymphoid Cells in Cancer.
Heinrich B; Korangy F
Front Immunol; 2022; 13():886520. PubMed ID: 35663967
[TBL] [Abstract][Full Text] [Related]
55. Migration and Tissue Tropism of Innate Lymphoid Cells.
Kim CH; Hashimoto-Hill S; Kim M
Trends Immunol; 2016 Jan; 37(1):68-79. PubMed ID: 26708278
[TBL] [Abstract][Full Text] [Related]
56. Development of human natural killer cells and other innate lymphoid cells.
Montaldo E; Vacca P; Moretta L; Mingari MC
Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
[TBL] [Abstract][Full Text] [Related]
57. Innate lymphoid cells, precursors and plasticity.
Gronke K; Kofoed-Nielsen M; Diefenbach A
Immunol Lett; 2016 Nov; 179():9-18. PubMed ID: 27394700
[TBL] [Abstract][Full Text] [Related]
58. Tuning cancer fate: the unremitting role of host immunity.
Calì B; Molon B; Viola A
Open Biol; 2017 Apr; 7(4):. PubMed ID: 28404796
[TBL] [Abstract][Full Text] [Related]
59. Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor.
Tumino N; Martini S; Munari E; Scordamaglia F; Besi F; Mariotti FR; Bogina G; Mingari MC; Vacca P; Moretta L
Int J Cancer; 2019 Sep; 145(6):1660-1668. PubMed ID: 30856277
[TBL] [Abstract][Full Text] [Related]
60. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
